Exact Sciences Corporation Profile Avatar - Palmy Investing

Exact Sciences Corporation

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated wit…
Medical - Diagnostics & Research
US, Madison [HQ]

Balance Sheet

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
25.00 96.00 96.00 112.00 146.00 311.00 364.00 377.00 598.00 1,524.00 3,505.00 4,925.00 6,684.00 6,226.00 6,471.00
Current
24.00 95.00 94.00 108.00 135.00 291.00 326.00 333.00 487.00 1,228.00 556.00 2,198.00 1,426.00 982.00 1,194.00
Non Current
- - - - 2.00 3.00 11.00 19.00 38.00 43.00 111.00 295.00 2,948.00 2,726.00 5,258.00 5,244.00 5,276.00
Liabilities
19.00 16.00 13.00 13.00 11.00 22.00 37.00 41.00 78.00 843.00 1,217.00 2,101.00 3,297.00 3,183.00 3,326.00
Current
6.00 7.00 7.00 11.00 7.00 17.00 26.00 30.00 68.00 136.00 236.00 575.00 517.00 412.00 514.00
Non Current
13.00 9.00 5.00 2.00 3.00 5.00 10.00 11.00 10.00 706.00 981.00 1,525.00 2,780.00 2,770.00 2,811.00
Equity
6.00 79.00 83.00 98.00 135.00 288.00 326.00 335.00 520.00 680.00 2,288.00 2,823.00 3,387.00 3,043.00 3,145.00
Stockholders' Equity
6.00 79.00 83.00 98.00 135.00 288.00 326.00 335.00 520.00 680.00 2,288.00 2,823.00 3,387.00 3,043.00 3,145.00
Retained Earnings
-181.00 -193.00 -221.00 -274.00 -320.00 -420.00 -578.00 -745.00 -860.00 -1,035.00 -1,119.00 -1,968.00 -2,641.00 -3,265.00 -3,469.00
Common Stock
- - - - - - - - - - - - - - 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Preferred Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Profit
-9.00 -11.00 -28.00 -52.00 -46.00 -100.00 -157.00 -167.00 -114.00 -175.00 -83.00 -848.00 -595.00 -623.00 -204.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
187.00 272.00 304.00 372.00 455.00 709.00 904.00 1,080.00 1,380.00 1,716.00 3,406.00 4,789.00 6,028.00 6,311.00 6,611.00
Loss Other Compr. Income
- - - - - - - - - - - - - - - - - - -1.00 - - - - -1.00 -5.00 1.00
End of EXAS's Analysis
CIK: 1124140 CUSIP: 30063P105 ISIN: US30063P1057 LEI: - UEI: -
Secondary Listings
EXAS has no secondary listings inside our databases.